<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:59:25Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5501769" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5501769</identifier>
        <datestamp>2018-03-01</datestamp>
        <setSpec>ict</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Integr Cancer Ther</journal-id>
              <journal-id journal-id-type="iso-abbrev">Integr Cancer Ther</journal-id>
              <journal-id journal-id-type="publisher-id">ICT</journal-id>
              <journal-id journal-id-type="hwp">spict</journal-id>
              <journal-title-group>
                <journal-title>Integrative Cancer Therapies</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1534-7354</issn>
              <issn pub-type="epub">1552-695X</issn>
              <publisher>
                <publisher-name>SAGE Publications</publisher-name>
                <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5501769</article-id>
              <article-id pub-id-type="pmcid">PMC5501769</article-id>
              <article-id pub-id-type="pmc-uid">5501769</article-id>
              <article-id pub-id-type="pmid">28102098</article-id>
              <article-id pub-id-type="pmid">28102098</article-id>
              <article-id pub-id-type="doi">10.1177/1534735416684947</article-id>
              <article-id pub-id-type="publisher-id">10.1177_1534735416684947</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A Randomized Double-Blind Placebo-Controlled Trial of Fruit and
Vegetable Concentrates on Intermediate Biomarkers in Head and Neck
Cancer</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Datta</surname>
                    <given-names>Mridul</given-names>
                  </name>
                  <degrees>PhD, RD</degrees>
                  <xref ref-type="aff" rid="aff1-1534735416684947">1</xref>
                  <xref ref-type="corresp" rid="corresp1-1534735416684947"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shaw</surname>
                    <given-names>Edward G.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff2-1534735416684947">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lesser</surname>
                    <given-names>Glenn J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Case</surname>
                    <given-names>L. Douglas</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vitolins</surname>
                    <given-names>Mara Z.</given-names>
                  </name>
                  <degrees>DrPH, RD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schneider</surname>
                    <given-names>Charles</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff4-1534735416684947">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Frizzell</surname>
                    <given-names>Bart</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sullivan</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lively</surname>
                    <given-names>Mark</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="aff3-1534735416684947">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Franzmann</surname>
                    <given-names>Elizabeth</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="aff5-1534735416684947">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hu</surname>
                    <given-names>Jennifer J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="aff5-1534735416684947">5</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1-1534735416684947"><label>1</label>Purdue University, West Lafayette, IN,
USA</aff>
              <aff id="aff2-1534735416684947"><label>2</label>Wake Forest Comprehensive Cancer Center,
Winston-Salem, NC, USA</aff>
              <aff id="aff3-1534735416684947"><label>3</label>Wake Forest School of Medicine,
Winston-Salem, NC, USA</aff>
              <aff id="aff4-1534735416684947"><label>4</label>Helen F. Graham Cancer Center, Newark,
DE, USA</aff>
              <aff id="aff5-1534735416684947"><label>5</label>University of Miami School of Medicine,
Miami, FL, USA</aff>
              <author-notes>
                <corresp id="corresp1-1534735416684947">Mridul Datta, Department of Nutrition
Science, Purdue University, 700 W State Street, West Lafayette, IN 47907, USA.
Email: <email>datta7@purdue.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>19</day>
                <month>1</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <volume>17</volume>
              <issue>1</issue>
              <fpage>115</fpage>
              <lpage>123</lpage>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>6</month>
                  <year>2018</year>
                </date>
                <date date-type="rev-recd">
                  <day>19</day>
                  <month>9</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>10</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2017</copyright-statement>
                <copyright-year>2017</copyright-year>
                <copyright-holder content-type="sage">SAGE Publications Inc unless otherwise noted.
Manuscript content on this site is licensed under Creative Commons
Licenses</copyright-holder>
                <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
                  <license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 3.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/3.0/">http://www.creativecommons.org/licenses/by-nc/3.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p><italic>Background.</italic> Head and neck cancer (HNC) patients are at an
increased risk for developing second primary tumors (SPTs). Diets rich in fruits
and vegetables (FVs) may lower HNC risk. FV concentrates may offer a potential
alternative to increasing FV intake. <italic>Methods.</italic> We conducted a
randomized, double-blind, placebo-controlled trial to evaluate whether Juice
PLUS+ (JP; a commercial product with multiple FV concentrates) has an effect on
p27 and Ki-67, biomarkers associated with the risk of SPTs. During 2004-2008, we
randomized 134 HNC patients to 12 weeks of JP (n = 72) or placebo (n = 62). Oral
cavity mucosal biopsies and whole blood were obtained at baseline and after 12
weeks. All participants were given the opportunity to receive JP for 5 years
following the end of the intervention period, and they were followed yearly for
the development of SPTs. <italic>Results.</italic> After 12 weeks, patients on
JP had significantly higher serum α-carotene (<italic>P</italic> = .009),
β-carotene (<italic>P</italic> &lt; .0001), and lutein (<italic>P</italic> =
.003) but did not differ significantly in p27 (<italic>P</italic> = .23) or
Ki-67 (<italic>P</italic> = .95). JP use following the initial 12-week trial was
not significantly associated with SPT prevention. <italic>Conclusions.</italic>
Despite increased serum micronutrient levels, our results do not suggest a
clinical benefit of JP in HNC patients. Future studies should focus on longer
intervention periods and/or modified supplement formulations with demonstrated
chemopreventive properties.</p>
              </abstract>
              <kwd-group>
                <kwd>fruit/vegetable concentrate</kwd>
                <kwd>surrogate end point biomarkers</kwd>
                <kwd>head and neck cancer</kwd>
                <kwd>p27</kwd>
                <kwd>Ki-67</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="award1-1534735416684947">
                  <funding-source id="funding1-1534735416684947">
                    <institution-wrap>
                      <institution>National Institutes of Health</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding1-1534735416684947">R21 CA 106205</award-id>
                </award-group>
                <award-group id="award2-1534735416684947">
                  <funding-source id="funding2-1534735416684947">
                    <institution-wrap>
                      <institution>National Institutes of Health</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding2-1534735416684947">R25CA122061</award-id>
                </award-group>
                <award-group id="award3-1534735416684947">
                  <funding-source id="funding3-1534735416684947">
                    <institution-wrap>
                      <institution>National Institutes of Health</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding3-1534735416684947">U10 CA 81851</award-id>
                </award-group>
                <award-group id="award4-1534735416684947">
                  <funding-source id="funding4-1534735416684947">
                    <institution-wrap>
                      <institution>NSA International</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="section1-1534735416684947">
              <title>Introduction</title>
              <p>Head and neck cancer (HNC) patients have a significantly higher rate of lipid
peroxidation and DNA damage<sup><xref rid="bibr1-1534735416684947" ref-type="bibr">1</xref><xref rid="bibr2-1534735416684947" ref-type="bibr"/>-<xref rid="bibr3-1534735416684947" ref-type="bibr">3</xref></sup> and are at an
increased risk of developing second primary tumors (SPTs). Continued smoking and
excess alcohol consumption contribute to increased oxidative stress and cancer risk.<sup><xref rid="bibr4-1534735416684947" ref-type="bibr">4</xref></sup> Low p27 (a cyclin-dependent kinase inhibitor; critical in cell cycle
regulation) and/or high Ki-67 (cell proliferation associated nuclear protein) has
been shown to correlate with tumor progression and poor prognosis in these
patients.<sup><xref rid="bibr5-1534735416684947" ref-type="bibr">5</xref><xref rid="bibr6-1534735416684947" ref-type="bibr"/><xref rid="bibr7-1534735416684947" ref-type="bibr"/>-<xref rid="bibr8-1534735416684947" ref-type="bibr">8</xref></sup> To improve survival, an
effective program of chemoprevention for second malignancies is essential in HNC
patients.</p>
              <p>Diets rich in fruits and vegetables (FVs) decrease HNC risk<sup><xref rid="bibr9-1534735416684947" ref-type="bibr">9</xref>,<xref rid="bibr10-1534735416684947" ref-type="bibr">10</xref></sup> and reduce markers of cellular
oxidative damage.<sup><xref rid="bibr11-1534735416684947" ref-type="bibr">11</xref></sup> However, ≥75% of the US population consumes FVs below the recommended amounts
for their age and gender group.<sup><xref rid="bibr12-1534735416684947" ref-type="bibr">12</xref></sup> Smoking is one of the most compelling risk factors for the development of HNC,<sup><xref rid="bibr13-1534735416684947" ref-type="bibr">13</xref></sup> and intake of FVs is even lower among smokers.<sup><xref rid="bibr14-1534735416684947" ref-type="bibr">14</xref><xref rid="bibr15-1534735416684947" ref-type="bibr"/>-<xref rid="bibr16-1534735416684947" ref-type="bibr">16</xref></sup> Lower FV intake<sup><xref rid="bibr14-1534735416684947" ref-type="bibr">14</xref><xref rid="bibr15-1534735416684947" ref-type="bibr"/>-<xref rid="bibr16-1534735416684947" ref-type="bibr">16</xref></sup> and free radicals from
cigarette smoke<sup><xref rid="bibr17-1534735416684947" ref-type="bibr">17</xref><xref rid="bibr18-1534735416684947" ref-type="bibr"/><xref rid="bibr19-1534735416684947" ref-type="bibr"/>-<xref rid="bibr20-1534735416684947" ref-type="bibr">20</xref></sup> may contribute to decreased
plasma antioxidant levels. Additionally, smoking appears to elicit dose-related
higher Ki-67 labeling indices in the bronchial epithelia of active smokers.<sup><xref rid="bibr21-1534735416684947" ref-type="bibr">21</xref></sup> Many clinical trials of vitamin and mineral supplements have failed to
demonstrate a strong association between isolated nutrients and the risk of
HNC,<sup><xref rid="bibr22-1534735416684947" ref-type="bibr">22</xref><xref rid="bibr23-1534735416684947" ref-type="bibr"/><xref rid="bibr24-1534735416684947" ref-type="bibr"/><xref rid="bibr25-1534735416684947" ref-type="bibr"/><xref rid="bibr26-1534735416684947" ref-type="bibr"/>-<xref rid="bibr27-1534735416684947" ref-type="bibr">27</xref></sup> indicating that perhaps a
single nutrient cannot replicate the synergistic effect of the numerous
chemoprotective compounds present in whole foods such as FVs. FV concentrates may
offer a potential alternative for increasing vitamin, mineral, and phytochemical
intakes.</p>
              <p>Several small studies of FV concentrate supplementation in healthy participants have
shown reduction of DNA damage, lower lipid peroxide levels, and a boost in the
immune response.<sup><xref rid="bibr28-1534735416684947" ref-type="bibr">28</xref><xref rid="bibr29-1534735416684947" ref-type="bibr"/>-<xref rid="bibr30-1534735416684947" ref-type="bibr">30</xref></sup> Juice PLUS+
(JP), a FV concentrate significantly increased serum antioxidants (such as
β-carotene, lutein, lycopene, retinol, vitamin C, α-tocopherol) in healthy
participants.<sup><xref rid="bibr28-1534735416684947" ref-type="bibr">28</xref>,<xref rid="bibr31-1534735416684947" ref-type="bibr">31</xref>,<xref rid="bibr32-1534735416684947" ref-type="bibr">32</xref></sup> However, to our knowledge, the efficacy of FV concentrates has
not been evaluated in HNC patients. We undertook this study to evaluate the effects
of JP (NSA International, Memphis, TN) on surrogate end point biomarkers (SEBs)
associated with the development of SPTs in patients with previous HNC. The primary
and secondary end points were p27 expression and Ki-67 proliferation rates,
respectively. We also evaluated whether the augmentation of SEBs by JP is influenced
by other factors, such as age, tumor site, and stage.</p>
            </sec>
            <sec sec-type="methods" id="section2-1534735416684947">
              <title>Methods</title>
              <sec id="section3-1534735416684947">
                <title>Study Population</title>
                <p>This randomized, double-blind, placebo-controlled trial to assess the effects of
JP on SEB in patients with previous HNC was conducted between January 2004 and
October 2008. Patients were followed for clinical events through January 2014.
Patients &gt;18 years old and free of HNC (minimum 6 months and maximum 3 years)
following completion of treatment for squamous cell carcinoma of the upper
aerodigestive tract, with life expectancy of &gt;6 months with no synchronous
tumors, a negative serum pregnancy test within 10 days of registration, normal
hematological parameters (hemoglobin ≥10 g/dL; white blood cells ≥3000/µL;
platelets ≥100000/µL), adequate liver (bilirubin ≤ 1.5 mg/dL, serum glutamic
oxaloacetic transaminase (SGOT) ≤ 40 U/L, serum glutamic pyruvic transaminase
(SGPT) ≤ 56 U/L) and renal function (creatinine ≤ 1.5 mg/dL), Eastern
Cooperative Oncology Group (ECOG) performance status (PS) 0 to 1, and no
consumption of JP within 6 months prior to enrollment were eligible to
participate.</p>
                <p>Candidates were ineligible if they had a concomitant malignancy other than
curatively treated HNC within the past 5 years (except non-melanoma skin cancer
and in situ carcinoma of the cervix), a serious medical or psychiatric illness
that prevented informed consent, or persistent nausea (&gt;grade 2 by National
Cancer Institute [NCI] Common Toxicity Criteria [CTC] Version 3.0) or if they
consumed mega doses of supplements such as &gt;10 000 IU or 3440 µg vitamin A,
&gt;1000 mg vitamin C, or &gt;800 IU or 537 mg vitamin E daily within the past 2
months.</p>
                <p>Patients were randomized within strata (tumor stage I, II, III, or IV; by tobacco
and alcohol use) to JP or placebo with equal probability. The institutional
review board at Wake Forest Baptist Health reviewed and approved the study
protocol (trial registration ID: NCT00064298; Comprehensive Cancer Center of
Wake Forest University Protocol no. 60A02). The research protocol was reviewed
and approved at the other participating Research Base sites (Southeast Cancer
Control Consortium, Upstate Carolina CCOP, Central Illinois CCOP, East Carolina
University, Harbin Clinic Radiation Oncology, Greater Phoenix CCOP, Alamance
Cancer Center and Louisiana State University MBCCOP). Participants were
recruited at multiple sites and recruitment sites were not required to record
screening data. Informed consent was obtained from all study participants.
Participants received a $10 gift certificate after baseline visit and a $40 gift
certificate on study completion. Beyond provision of JP capsules, NSA
International (Memphis, TN) had no role in the study design, data collection,
analysis, and/or interpretation.</p>
              </sec>
              <sec id="section4-1534735416684947">
                <title>Data Collection and Follow-up</title>
                <p>Research nurses conducted screening interviews to obtain information on medical
history, tobacco and alcohol use, and PS and to administer the baseline HNC
questionnaire. After the interview, the research nurse collected blood for
screening evaluation. Candidates with normal blood chemistry were invited to
initiate the 1-week run-in period, which involved taking placebo pills as
prescribed and maintaining a complete and accurate medication diary. The pill
bottle was returned to the nurse who counted pills and compared with the diary.
Study participants with &gt;75% compliance were randomly assigned to receive
either JP or placebo for 12 weeks. Medication diary and pill counts were
collected at baseline and at the end of 12 weeks of intervention.</p>
              </sec>
              <sec id="section5-1534735416684947">
                <title>Study Supplementation</title>
                <p>JP is a proprietary blend of dried FV powders extracted from apples, oranges,
pineapples, papaya, cranberries, and peaches (orchard blend); carrots, parsley,
beets, broccoli, kale, cabbage, spinach, and tomatoes (garden blend); and citrus
bioflavonoids, calcium ascorbate and carbonate, <italic>Lactobacillus
acidophilus</italic>, d-α tocopherol, mixed tocopherols, <italic>Dunaliella
salina</italic>, β-carotene, and folic acid. The nutritional profile of JP
capsules is provided in <xref rid="table1-1534735416684947" ref-type="table">Table 1</xref>. The FV concentrates are encapsulated separately in hard
gelatin capsules to provide 850 mg of fruit powder and 750 mg of vegetable
powder per capsule. Test supplements were obtained from the same product lot.
Based on the guidelines established by the Food and Drug Administration, FV
concentrates are generally recognized as safe. JP has previously been studied in
healthy participants<sup><xref rid="bibr29-1534735416684947" ref-type="bibr">29</xref>,<xref rid="bibr31-1534735416684947" ref-type="bibr">31</xref>,<xref rid="bibr33-1534735416684947" ref-type="bibr">33</xref></sup> and women with ovarian cancer, with no reported toxic effects.<sup><xref rid="bibr34-1534735416684947" ref-type="bibr">34</xref></sup> Consequently, for this study, we chose the JP dose previously evaluated
(1 capsule each of orchard and garden blend administered twice daily).</p>
                <table-wrap id="table1-1534735416684947" orientation="portrait" position="float">
                  <label>Table 1.</label>
                  <caption>
                    <p>Nutrition Composition of Juice PLUS+.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_1534735416684947-table1"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" colspan="1">Nutrient</th>
                          <th align="center" colspan="2" rowspan="1">Garden Blend<sup><xref ref-type="table-fn" rid="table-fn1-1534735416684947">a</xref></sup> (Blended Vegetables)<hr/></th>
                          <th align="center" colspan="2" rowspan="1">Orchard Blend<sup><xref ref-type="table-fn" rid="table-fn1-1534735416684947">a</xref></sup> (Blended Fruit)<hr/></th>
                          <th align="center" colspan="2" rowspan="1">Total Daily Intake<sup><xref ref-type="table-fn" rid="table-fn2-1534735416684947">b</xref></sup><hr/></th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Actual</th>
                          <th align="center" rowspan="1" colspan="1">Percentage Daily Value</th>
                          <th align="center" rowspan="1" colspan="1">Actual</th>
                          <th align="center" rowspan="1" colspan="1">Percentage Daily Value</th>
                          <th align="center" rowspan="1" colspan="1">Actual</th>
                          <th align="center" rowspan="1" colspan="1">Percentage Daily Value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">Calories (kcal)</td>
                          <td rowspan="1" colspan="1">5</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">5</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">10</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Total fat (g)</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Cholesterol (mg)</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1">0</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Sodium (mg)</td>
                          <td rowspan="1" colspan="1">10</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1">5</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">15</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Total carbohydrate (g)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Dietary fiber (g)</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1">2</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">&lt;2</td>
                          <td rowspan="1" colspan="1">3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Sugars (g)</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">&lt;2</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Protein (g)</td>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">&lt;1</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">&lt;2</td>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Vitamin A (100% as β-carotene)</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">140</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">110</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">250</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Vitamin E</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">80</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">70</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">150</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Vitamin C</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">70</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">320</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">390</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Folate</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">70</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">35</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">105</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Calcium</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">4</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">6</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn1-1534735416684947">
                      <label>a</label>
                      <p>Nutrition information per 2 capsules each.</p>
                    </fn>
                    <fn id="table-fn2-1534735416684947">
                      <label>b</label>
                      <p>1 Fruit and vegetable capsule each in the morning and evening.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Participants received 2 capsules of either JP or placebo in the morning and 2 in
the afternoon/evening. If the participant was unable to swallow the pills, the
capsules were opened and the contents sprinkled over food, and the participant
was instructed to consume all the food containing the capsule contents. The
capsule contents of JP and placebo were similar in appearance, so that the
participants could not discern their group assignment even if the capsules were
opened. Study participants were instructed to maintain their usual dietary
habits and lifestyle during the trial. Telephone interviews were conducted at
weeks 1, 2, 3, 4, and 8 of supplementation to evaluate side effects and
tolerance.</p>
                <p>Storage and distribution of JP and placebo pills was handled by Biologics, Inc
(Raleigh, NC). On notification of participant enrollment in the study,
Biologics, Inc shipped a 12-week supply of either JP or placebo to the
participant’s address.</p>
              </sec>
              <sec id="section6-1534735416684947">
                <title>Sample Collection and Laboratory Procedures</title>
                <p>At baseline, following a complete head and neck examination by an
otolaryngologist or a radiation oncologist, buccal mucosa biopsies were taken
from the left side of the mouth. This area was chosen for its accessibility. At
12 weeks, a buccal mucosa biopsy was obtained from the right side of the mouth.
Biopsies were obtained under local anesthesia. A single biopsy measuring a
minimum 1 cm × 2 mm was obtained and divided into 4 pieces. One piece of the
biopsy was immediately fixed in 10% buffered formalin. The other 3 biopsy
sections were frozen in dry ice. Approximately 30 mL whole blood was obtained,
tubes were centrifuged, and the separated serum was stored at −70°C until
analyzed.</p>
              </sec>
              <sec id="section7-1534735416684947">
                <title>Serum Micronutrient Levels</title>
                <p>The samples were processed under subdued yellow/orange lighting and the
lipid-soluble vitamin assays were conducted based on methods adopted from Hess
et al<sup><xref rid="bibr35-1534735416684947" ref-type="bibr">35</xref></sup> and Aebischer et al.<sup><xref rid="bibr36-1534735416684947" ref-type="bibr">36</xref></sup> For this, 200 µL of plasma or standard solution and internal standard was
deproteinized with 1 mL ethanol followed by 2 mL hexane stabilized with 30 mM
butylated hydroxy toluene (BHT) and buffer. Samples were extracted twice with
hexane/BHT under argon. The combined organic layers were dried under nitrogen
and reconstituted with 200 µL of 30% methanol, 30% dioxane, and 40%
acetonitrile. Two detectors were required to monitor the necessary wavelengths
to quantify the analytes at their absorbance maxima to ensure sensitivity.
Analytes were separated on a Beckman ODS 5-µm, 250 × 4.6 mm<sup>2</sup> column
(Beckman Coulter Inc, Brea, CA). The isocratic mobile phase consisted of 680 mL
acetonitrile, 220 mL tetrahydrofuran, 68 mL methanol, and 28 mL of a 1% ammonium
acetate solution. The analyte limits of detection were determined by Hess et al<sup><xref rid="bibr35-1534735416684947" ref-type="bibr">35</xref></sup>: α-carotene 10 µg/L, β-carotene 10 µg/L, β-cryptoxanthin 10 µg/L,
lycopene 5 µg/L, retinol 20 µg/L, α-tocopherol 0.05 mg/L, and γ-tocopherol 0.05
mg/L. A 7-point standard curve along with low and high controls was run daily
with participant samples. Assays where the controls varied by &gt;10% of
expected values were repeated.</p>
              </sec>
              <sec id="section8-1534735416684947">
                <title>Histopathological and Immunohistochemistry Evaluation</title>
                <p>Standard microscopic examination of all tissue biopsies was done using cytologic
and architectural pathologic criteria to differentiate reactive from dysplastic
changes. Formalin-fixed tissue was paraffin embedded, and 4-µm sections were cut
and put onto slides (Baxter, Charlotte, NC). These sections were air dried,
deparaffinized with xylene, hydrated, and antigen retrieved, and then the slides
were stained, using an automated stainer for expression of p27 and Ki-67 and a
streptavidin-biotin peroxidase technique with an anti-human p27 mouse monoclonal
antibody (Transduction Laboratories, Lexington, KY) or an anti-human Ki-67 mouse
monoclonal antibody (Immunotech, France). The slides were counterstained with
Gill’s hematoxylin and analyzed for percentage of cells stained and stain
intensity. In each study, a negative control was also run, where the primary
treatment contained no primary antibody.</p>
              </sec>
              <sec id="section9-1534735416684947">
                <title>Toxicity and Response Evaluation Criteria</title>
                <p>Toxicity was determined using the NCI-CTC, v3.0 for toxicity and adverse event reporting.<sup><xref rid="bibr37-1534735416684947" ref-type="bibr">37</xref></sup> The study chairman was notified immediately by telephone of any
unexpected, life-threatening (grade 4), or fatal (grade 5) adverse event, with
an attribution of possible, probable, or definite cause. Queried toxicities
included anorexia, nausea, vomiting, diarrhea, fatigue, fever, and heartburn. No
toxicity related to JP was expected, but because gastrointestinal toxicity was a
potential concern, the research nurse conducted telephone interviews weekly
during the first month of the intervention. Participants were asked to rate
symptoms of gastrointestinal upset on a 5-point scale. Participants who
experienced ≥grade 3 symptoms would have been withdrawn from the study. The
institutional review board was to be notified of any study-related (JP) adverse
events. Response to supplements was determined by comparing p27 and Ki-67
measured at baseline and after 12 weeks of supplementation.</p>
              </sec>
              <sec id="section10-1534735416684947">
                <title>Statistical Analysis</title>
                <p>The primary objective of this study was to assess the effects of JP on p27, the
biomarker quantitating cell-cycle regulation. The sample size was based on a
<italic>t</italic>-test comparison between treatment groups at the 5%,
2-sided level of significance. The sample sizes per group needed to detect a 20%
relative difference between groups (assuming a mean ± SD p27 value in the
control group of 34.68 ± 11.41 from the Mineta et al<sup><xref rid="bibr7-1534735416684947" ref-type="bibr">7</xref></sup> study) with 80%, 85%, and 90% power were 46, 52, and 60, respectively.
Assuming a 40% drop-out rate, we planned to accrue 200 participants to provide
90% power. The drop-out rate was much lower than anticipated (only 8%), so
accrual was terminated after 134 participants. Patients were stratified by
tobacco and/or alcohol use and primary tumor stage (stage I, II, III, and IV)
and randomized within strata to JP or placebo groups with equal probability
using variably sized permuted blocks. Block sizes of varying length were
determined randomly to ensure that future assignments could not be inferred from
past assignments. The randomization allocation sequence generated by a
statistician at the Wake Forest University Comprehensive Cancer Center was
stored as a database table and accessed via an on-line
registration/randomization facility. Because participants were enrolled at
multiple sites across the United States, research staff at these sites enrolled
participants, and group assignment was automatically done by the randomization
facility on registration. Participants, care givers, and those who did the
outcome assessments were all blinded to the intervention.</p>
                <p>Participant characteristics and outcome measures are summarized using descriptive
statistics for each treatment group. Because of some bad sections and missing
data, some participants had outcome data at one time point but not the other. A
mixed-effects, repeated-measures model fit using an unstructured covariance
matrix was used to assess the effect of treatment arm on the primary (p27) and
secondary outcome measures (Ki-67), using all data collected. This model was
constrained, so that the baseline estimate was the same in both groups, as
appropriate for randomized trials.<sup><xref rid="bibr38-1534735416684947" ref-type="bibr">38</xref></sup> Posttreatment least-square (LS) means and standard errors for each
treatment arm were estimated along with 95% CIs for the treatment differences.
Analysis of covariance (ANCOVA) was then used to assess the effect of JP after
adjusting for baseline characteristics (age, sex, race, body mass index [BMI],
performance status (PS), stage, and tobacco and alcohol use), the effect of
characteristics on the change in p27 and Ki-67, and whether the effect of JP was
influenced by these characteristics.</p>
                <p>All participants were given the opportunity to receive JP for 5 years following
the end of the intervention. Participants were followed yearly for those 5 years
for the development of SPTs and to record JP use. In an unplanned, exploratory
analysis, we assessed the association between JP use and the risk of SPTs. We
used self-reported JP intake to create event history records and the occurrence
of events. For example, a participant may have used JP for the first 2 years and
not for the last 3 years of follow-up. A Cox proportional hazards regression
model utilizing a counting process input<sup><xref rid="bibr39-1534735416684947" ref-type="bibr">39</xref></sup> (which utilizes multiple start/stop records per patient) was used to
assess the effect of JP on the risk of secondary events.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="section11-1534735416684947">
              <title>Results</title>
              <p>Previously diagnosed HNC patients (n = 134) were accrued and randomly assigned to
receive either JP (n = 72) or a placebo (n = 62). Participant ages ranged from 30 to
82 years, with a median age of 59 years. Most participants were male (84%) and
Caucasian (83%), and 12% (n = 16) were obese (BMI ≥ 30 kg/m<sup>2</sup>). In all,
22% (n = 30) still used tobacco products, and 44% (n = 59) continued to use alcohol
(<xref rid="table2-1534735416684947" ref-type="table">Table 2</xref>).
Participant characteristics were similar between treatment groups (<xref rid="table2-1534735416684947" ref-type="table">Table 2</xref>), and most (92%)
remained in the study for the entire 12 weeks. Three refused participation (JP: n =
2; placebo: n = 1), 3 had disease recurrence (JP: n = 2; placebo: n = 1), 1 expired
(placebo), and 4 were lost to follow-up (JP and placebo: n = 2 each). Overall,
self-reported participant compliance was 94% on both JP and placebo.</p>
              <table-wrap id="table2-1534735416684947" orientation="portrait" position="float">
                <label>Table 2.</label>
                <caption>
                  <p>Summary of Participant Characteristics in the Juice PLUS+ Supplementation in
the Head and Neck Cancer Trial.</p>
                </caption>
                <alternatives>
                  <graphic xlink:href="10.1177_1534735416684947-table2"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" span="1"/>
                      <col align="char" char="." span="1"/>
                      <col align="char" char="." span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Juice PLUS+<hr/></th>
                        <th align="center" rowspan="1" colspan="1">Placebo<hr/></th>
                      </tr>
                      <tr>
                        <th rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">n (%)</th>
                        <th align="center" rowspan="1" colspan="1">n (%)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Participants</td>
                        <td rowspan="1" colspan="1">72 (100)</td>
                        <td rowspan="1" colspan="1">62 (100)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Age</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Median (range)</td>
                        <td rowspan="1" colspan="1">58 (30-82)</td>
                        <td rowspan="1" colspan="1">59 (41-82)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> ≥60 years</td>
                        <td rowspan="1" colspan="1">31 (43)</td>
                        <td rowspan="1" colspan="1">31 (50)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Gender</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Female</td>
                        <td rowspan="1" colspan="1">11 (15)</td>
                        <td rowspan="1" colspan="1">10 (16)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Male</td>
                        <td rowspan="1" colspan="1">61 (85)</td>
                        <td rowspan="1" colspan="1">52 (84)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Race/Ethnicity</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Black</td>
                        <td rowspan="1" colspan="1">4 (6)</td>
                        <td rowspan="1" colspan="1">7 (11)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Hispanic</td>
                        <td rowspan="1" colspan="1">7 (10)</td>
                        <td rowspan="1" colspan="1">2 (3)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> White</td>
                        <td rowspan="1" colspan="1">58 (81)</td>
                        <td rowspan="1" colspan="1">53 (85)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Other/Unknown</td>
                        <td rowspan="1" colspan="1">3 (4)</td>
                        <td rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Body mass index</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Median (range)</td>
                        <td rowspan="1" colspan="1">25.0 (16.5-39.8)</td>
                        <td rowspan="1" colspan="1">25.1 (16.2-36.6)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Underweight/Normal (&lt;25 kg/m2)</td>
                        <td rowspan="1" colspan="1">35 (49)</td>
                        <td rowspan="1" colspan="1">28 (45)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Overweight (25-29.9 kg/m2)</td>
                        <td rowspan="1" colspan="1">30 (42)</td>
                        <td rowspan="1" colspan="1">25 (40)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Obese (≥30 kg/m2)</td>
                        <td rowspan="1" colspan="1">7 (10)</td>
                        <td rowspan="1" colspan="1">9 (15)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Performance status</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> 0</td>
                        <td rowspan="1" colspan="1">60 (83)</td>
                        <td rowspan="1" colspan="1">53 (85)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> 1</td>
                        <td rowspan="1" colspan="1">12 (17)</td>
                        <td rowspan="1" colspan="1">9 (15)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Stage<sup><xref ref-type="table-fn" rid="table-fn3-1534735416684947">a</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> I-II</td>
                        <td rowspan="1" colspan="1">26 (36)</td>
                        <td rowspan="1" colspan="1">20 (32)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> III-IV</td>
                        <td rowspan="1" colspan="1">46 (64)</td>
                        <td rowspan="1" colspan="1">42 (68)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Treatment</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Surgery alone</td>
                        <td rowspan="1" colspan="1">11 (15)</td>
                        <td rowspan="1" colspan="1">10 (16)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Radiation therapy alone</td>
                        <td rowspan="1" colspan="1">4 (6)</td>
                        <td rowspan="1" colspan="1">3 (5)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Surgery + Radiation therapy</td>
                        <td rowspan="1" colspan="1">12 (17)</td>
                        <td rowspan="1" colspan="1">18 (29)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Radiation + Chemotherapy</td>
                        <td rowspan="1" colspan="1">22 (31)</td>
                        <td rowspan="1" colspan="1">15 (24)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Surgery + Radiation + Chemotherapy</td>
                        <td rowspan="1" colspan="1">23 (32)</td>
                        <td rowspan="1" colspan="1">16 (26)</td>
                      </tr>
                      <tr>
                        <td colspan="3" rowspan="1">Lifestyle characteristics</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Alcohol use<sup><xref ref-type="table-fn" rid="table-fn3-1534735416684947">a</xref></sup></td>
                        <td rowspan="1" colspan="1">32 (44)</td>
                        <td rowspan="1" colspan="1">27 (44)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Tobacco use<sup><xref ref-type="table-fn" rid="table-fn3-1534735416684947">a</xref></sup></td>
                        <td rowspan="1" colspan="1">16 (22)</td>
                        <td rowspan="1" colspan="1">14 (23)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="table-fn3-1534735416684947">
                    <label>a</label>
                    <p>Factors used for stratification.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="section12-1534735416684947">
                <title>Serum Micronutrient Levels</title>
                <p>A significant increase in serum α-carotene (<italic>P</italic> = .004),
β-carotene (<italic>P</italic> &lt; .0001), lutein (<italic>P</italic> = .0004),
retinol (<italic>P</italic> = .045), and α-tocopherol (<italic>P</italic> =
.023) and a decrease in serum γ-tocopherol (<italic>P</italic> = .04) was
observed after 12 weeks of JP. No significant change was observed in tocopherols
or carotenoids (except lycopene; <italic>P</italic> = .019) in the placebo
group. Statistically significant between-group differences were observed (in the
change from baseline to the end of 12 weeks; <xref rid="table3-1534735416684947" ref-type="table">Table 3</xref>) in serum α-carotene
(<italic>P</italic> = .009), β-carotene (<italic>P</italic> &lt; .0001),
lutein (<italic>P</italic> = .003), and γ-tocopherol (<italic>P</italic> =
.015).</p>
                <table-wrap id="table3-1534735416684947" orientation="portrait" position="float">
                  <label>Table 3.</label>
                  <caption>
                    <p>Serum Micronutrient Levels Pretreatment and Posttreatment (Matched
Pairs).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_1534735416684947-table3"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="center" colspan="5" rowspan="1">Juice PLUS+<hr/></th>
                          <th align="center" colspan="5" rowspan="1">Placebo<hr/></th>
                          <th align="center" rowspan="1" colspan="1">Between Groups<hr/></th>
                        </tr>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">Baseline, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1">12 Weeks, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1">Change, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">Baseline, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1">12 Weeks, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1">Change, Mean ± SD</th>
                          <th align="center" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                          <th align="center" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">α-Carotene (µg/L)</td>
                          <td rowspan="1" colspan="1">52</td>
                          <td rowspan="1" colspan="1">103 ± 43.8</td>
                          <td rowspan="1" colspan="1">117 ± 54.1</td>
                          <td rowspan="1" colspan="1">13.5 ± 31.8</td>
                          <td rowspan="1" colspan="1">.004</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">117 ± 97.7</td>
                          <td rowspan="1" colspan="1">115 ± 89.8</td>
                          <td rowspan="1" colspan="1">−1.59 ± 23.7</td>
                          <td rowspan="1" colspan="1">.656</td>
                          <td rowspan="1" colspan="1">.009</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">β-Carotene (µg/L)</td>
                          <td rowspan="1" colspan="1">52</td>
                          <td rowspan="1" colspan="1">484 ± 414</td>
                          <td rowspan="1" colspan="1">1900 ± 1950</td>
                          <td rowspan="1" colspan="1">1420 ± 1870</td>
                          <td rowspan="1" colspan="1">&lt;.0001</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">504 ± 577</td>
                          <td rowspan="1" colspan="1">549 ± 741</td>
                          <td rowspan="1" colspan="1">45.5 ± 209</td>
                          <td rowspan="1" colspan="1">.151</td>
                          <td rowspan="1" colspan="1">&lt;.0001</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">β-Cryptoxanthin (µg/L)</td>
                          <td rowspan="1" colspan="1">52</td>
                          <td rowspan="1" colspan="1">121 ± 100</td>
                          <td rowspan="1" colspan="1">145 ± 126</td>
                          <td rowspan="1" colspan="1">24.5 ± 117</td>
                          <td rowspan="1" colspan="1">.136</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">127 ± 79.3</td>
                          <td rowspan="1" colspan="1">126 ± 70.4</td>
                          <td rowspan="1" colspan="1">−1.28 ± 29.9</td>
                          <td rowspan="1" colspan="1">.776</td>
                          <td rowspan="1" colspan="1">.130</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Lutein (µg/L)</td>
                          <td rowspan="1" colspan="1">52</td>
                          <td rowspan="1" colspan="1">299 ± 111</td>
                          <td rowspan="1" colspan="1">349 ± 133</td>
                          <td rowspan="1" colspan="1">50.3 ± 95.4</td>
                          <td rowspan="1" colspan="1">.0004</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">362 ± 130</td>
                          <td rowspan="1" colspan="1">361 ± 126</td>
                          <td rowspan="1" colspan="1">−1.43 ± 71.3</td>
                          <td rowspan="1" colspan="1">.893</td>
                          <td rowspan="1" colspan="1">.003</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Lycopene (µg/L)</td>
                          <td rowspan="1" colspan="1">52</td>
                          <td rowspan="1" colspan="1">558 ± 309</td>
                          <td rowspan="1" colspan="1">901 ± 1410</td>
                          <td rowspan="1" colspan="1">343 ± 1400</td>
                          <td rowspan="1" colspan="1">.084</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">549 ± 297</td>
                          <td rowspan="1" colspan="1">622 ± 307</td>
                          <td rowspan="1" colspan="1">72.4 ± 199</td>
                          <td rowspan="1" colspan="1">.019</td>
                          <td rowspan="1" colspan="1">.175</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Retinol (µg/L)</td>
                          <td rowspan="1" colspan="1">51</td>
                          <td rowspan="1" colspan="1">3150 ± 923</td>
                          <td rowspan="1" colspan="1">3370 ± 905</td>
                          <td rowspan="1" colspan="1">220 ± 765</td>
                          <td rowspan="1" colspan="1">.045</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">3370 ± 898</td>
                          <td rowspan="1" colspan="1">3410 ± 868</td>
                          <td rowspan="1" colspan="1">44.7 ± 541</td>
                          <td rowspan="1" colspan="1">.582</td>
                          <td rowspan="1" colspan="1">.194</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">α-Tocopherol (mg/L)</td>
                          <td rowspan="1" colspan="1">51</td>
                          <td rowspan="1" colspan="1">10 300 ± 3810</td>
                          <td rowspan="1" colspan="1">11 700 ± 4440</td>
                          <td rowspan="1" colspan="1">1340 ± 4100</td>
                          <td rowspan="1" colspan="1">.023</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">10 900 ± 3850</td>
                          <td rowspan="1" colspan="1">11 200 ± 3100</td>
                          <td rowspan="1" colspan="1">247 ± 2840</td>
                          <td rowspan="1" colspan="1">.564</td>
                          <td rowspan="1" colspan="1">.128</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">γ-Tocopherol (mg/L)</td>
                          <td rowspan="1" colspan="1">51</td>
                          <td rowspan="1" colspan="1">3900 ± 1690</td>
                          <td rowspan="1" colspan="1">3470 ± 1120</td>
                          <td rowspan="1" colspan="1">−432 ± 1490</td>
                          <td rowspan="1" colspan="1">.043</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">3680 ± 995</td>
                          <td rowspan="1" colspan="1">3870 ± 1190</td>
                          <td rowspan="1" colspan="1">186 ± 904</td>
                          <td rowspan="1" colspan="1">.174</td>
                          <td rowspan="1" colspan="1">.015</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="section13-1534735416684947">
                <title>P27 and Ki-67 Expression Levels</title>
                <p>Baseline raw and posttreatment LS means for p27 and Ki-67 are shown in <xref rid="table4-1534735416684947" ref-type="table">Table 4</xref>. The estimated
treatment effect (LS mean for JP − LS mean for placebo) for p27 was 2.49 (95% CI
= −1.63 to 6.61; <italic>P</italic> = .23) and for Ki-67 was 0.14 (95% CI = 4.02
to 4.30; <italic>P</italic> = .95). Results were similar after adjusting for
covariates. There were no significant pairwise interactions with arm. None of
the covariates were significantly associated with the change in p27. Only PS was
significantly associated with the change in Ki-67 (<italic>P</italic> = .037).
Those with worse PS had lower posttreatment Ki-67 levels.</p>
                <table-wrap id="table4-1534735416684947" orientation="portrait" position="float">
                  <label>Table 4.</label>
                  <caption>
                    <p>Changes in Oral Biopsy p27 and Ki-67 Expression.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_1534735416684947-table4"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" colspan="1">Baseline</th>
                          <th align="center" colspan="3" rowspan="1">Juice PLUS+<hr/></th>
                          <th align="center" colspan="3" rowspan="1">Placebo<hr/></th>
                          <th align="center" rowspan="2" colspan="1"><italic>P</italic> Value<sup><xref ref-type="table-fn" rid="table-fn4-1534735416684947">a</xref></sup></th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">Mean</th>
                          <th align="center" rowspan="1" colspan="1">SD</th>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">Mean</th>
                          <th align="center" rowspan="1" colspan="1">SD</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">Percentage p27 expression</td>
                          <td rowspan="1" colspan="1">54</td>
                          <td rowspan="1" colspan="1">18.6</td>
                          <td rowspan="1" colspan="1">11.2</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">15.1</td>
                          <td rowspan="1" colspan="1">9.54</td>
                          <td rowspan="1" colspan="1">.10</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Percentage Ki-67 expression</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">26.8</td>
                          <td rowspan="1" colspan="1">8.03</td>
                          <td rowspan="1" colspan="1">42</td>
                          <td rowspan="1" colspan="1">26.2</td>
                          <td rowspan="1" colspan="1">8.31</td>
                          <td rowspan="1" colspan="1">.75</td>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">12 Weeks</th>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">LS Mean</th>
                          <th align="center" rowspan="1" colspan="1">SE</th>
                          <th align="center" rowspan="1" colspan="1">n</th>
                          <th align="center" rowspan="1" colspan="1">LS Mean</th>
                          <th align="center" rowspan="1" colspan="1">SE</th>
                          <th align="center" rowspan="1" colspan="1"><italic>P</italic> Value<sup><xref ref-type="table-fn" rid="table-fn4-1534735416684947">a</xref></sup></th>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Percentage p27 expression</td>
                          <td rowspan="1" colspan="1">57</td>
                          <td rowspan="1" colspan="1">17.0</td>
                          <td rowspan="1" colspan="1">1.39</td>
                          <td rowspan="1" colspan="1">45</td>
                          <td rowspan="1" colspan="1">14.5</td>
                          <td rowspan="1" colspan="1">1.57</td>
                          <td rowspan="1" colspan="1">.23</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Percentage Ki-67 expression</td>
                          <td rowspan="1" colspan="1">47</td>
                          <td rowspan="1" colspan="1">27.1</td>
                          <td rowspan="1" colspan="1">1.43</td>
                          <td rowspan="1" colspan="1">40</td>
                          <td rowspan="1" colspan="1">27.0</td>
                          <td rowspan="1" colspan="1">1.55</td>
                          <td rowspan="1" colspan="1">.95</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn4-1534735416684947">
                      <label>a</label>
                      <p><italic>t</italic>-test at baseline; mixed-effects model at 12
weeks.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="section14-1534735416684947">
                <title>Clinical Outcomes at 5-Year Follow-up</title>
                <p>All participants were given the opportunity to receive JP for 5 years following
the end of the intervention period. Although 86 of 111 participants with
posttrial follow-up data chose to receive JP, not all participants took JP for
the entire follow-up period. JP use was reported in approximately 67% of the
follow-up visits. A total of 19 participants had SPTs, 16 occurring in the
follow-up period. JP use was associated with a lower risk of a SPT, although
this effect was not statistically significant (hazard ratio [HR] = 0.56; 95% CI
= 0.20 to 1.57; <italic>P</italic> = .27). After adjusting for patient
characteristics, the HR was 0.88 (95% CI = 0.25 to 3.11).</p>
              </sec>
              <sec id="section15-1534735416684947">
                <title>Adverse Effects/Toxicities</title>
                <p>Although 7 adverse events were reported (JP = 3; placebo = 4), none were related
to JP. Queried toxicities included anorexia, nausea, vomiting, diarrhea,
fatigue, fever, and heartburn. Heartburn occurred most commonly (13%) but was
mild in all but 2 patients. Fatigue was the only toxicity with severity grade 3
(n = 1; placebo group). All other toxicities occurred in &lt;7% of the
participants, with no significant differences between groups.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="section16-1534735416684947">
              <title>Discussion</title>
              <p>The current study evaluated the effect of JP, a FV concentrate, on the expression of
p27 and Ki-67 and the development of SPTs in patients with previous HNC. We found no
significant group differences between p27, Ki-67, and any of the carotenoids or
tocopherols between the JP and placebo groups. An association has been reported
between tocopherols, vitamin A, and Ki-67 proliferation. Hittelman et al<sup><xref rid="bibr40-1534735416684947" ref-type="bibr">40</xref></sup> reported a significant decrease in Ki-67 proliferation after administration
of 1 mg/kg 13-cis-retinoic acid (a biologically active vitamin A metabolite) and
1200 IU α-tocopherol (<italic>P</italic> = .04) in the bronchial epithelium of
former smokers. Participants in our study received 500% of vitamin A as β-carotene
and 300% (4500 mg/6600 IU) of vitamin E (primarily as α-tocopherol), without an
effect on the Ki-67 proliferation rate.</p>
              <p>We observed significant increase in the serum concentrations of α-tocopherol and
several carotenoids (α- and β-carotene, lutein, retinol) but not β-cryptoxanthin or
lycopene in the JP group. It is unclear how much β-cryptoxanthin and lycopene were
present in JP because the exact amount was not quantified. We observed a significant
decrease in γ-tocopherol (<xref rid="table3-1534735416684947" ref-type="table">Table
3</xref>) after 12 weeks of JP. Despite vitamin E intake at 150% of daily value
(22.50 mg vs recommended dietary allowance of 15 mg/d) and the abundance of
γ-tocopherol in the American diet, lower levels of γ-tocopherol may reflect added
α-tocopherol in JP and/or increased metabolism of γ-tocopherol. High doses of
α-tocopherol may interfere with the blood and tissue concentration of other
tocopherols such as γ- and δ-tocopherol.<sup><xref rid="bibr41-1534735416684947" ref-type="bibr">41</xref>,<xref rid="bibr42-1534735416684947" ref-type="bibr">42</xref></sup> Additionally, smoking and
systemic inflammation may also affect tocopherol metabolism.<sup><xref rid="bibr41-1534735416684947" ref-type="bibr">41</xref></sup> Even though we did not measure serum inflammatory markers, we anticipate high
systemic inflammation in our participants because almost one-fourth continued to
smoke (<xref rid="table2-1534735416684947" ref-type="table">Table 2</xref>).
Additionally, despite increased circulating carotenoids and α-tocopherol, JP use did
not have a significant effect on the incidence of SPTs in the 5-year follow-up
period.</p>
              <p>To our knowledge, this is the first randomized, double-blind, placebo-controlled
trial to investigate the effect of JP on the expression of p27 and Ki-67. We also
report on an observational 5-year follow-up of clinical outcomes in patients with
previous HNC, some of whom took JP. Although our findings for long-term JP use and
clinical outcomes were not significant, JP use during and/or after the initial trial
was associated with a slightly lower rate for SPTs (HR = 0.88 after adjustment for
covariates). Adding to the strength of the study design, we also assessed the serum
concentration of several carotenoids and tocopherols that have previously been shown
to reduce cancer risk in clinical trials. Overall, 92% of the patients completed the
study, and we observed a high patient-reported compliance (94%) in both the JP and
placebo groups. These relatively high completion and compliance rates may be
attributed to the run-in procedures instituted prior to participant randomizations
(only participants with &gt;75% compliance were randomized into study groups).</p>
              <p>Limitations of this study include lost samples as a result of power outage (Hurricane
Katrina) and samples with bad sections, resulting in usable posttreatment p27 data
for 102 participants instead of the 120 planned and lower power than anticipated.
However, the LS estimate of the treatment effect was less than half of that
anticipated, so it is unlikely that the extra samples would have made a meaningful
difference. It is possible that the 12-week supplementation period was too short to
see an impact on the SEBs. It is plausible that increased inflammation and metabolic
aberrations significantly increase nutrient needs in HNC patients, which were
insufficiently met by JP and, thus, was unsuccessful in decreasing SEBs associated
with SPTs. Moreover, continued tobacco and alcohol use increase oxidative stress,
further compounding the problem. The results of this study may also not be
generalizable to other cancers because HNC patients are at a higher risk for
developing SPTs. Finally, although many participants agreed to consume JP after the
completion of the clinical trial, JP use during this follow-up period was not
randomized, creating limitations in the usefulness of the data and in the
interpretation of results.</p>
            </sec>
            <sec sec-type="conclusions" id="section17-1534735416684947">
              <title>Conclusions</title>
              <p>In conclusion, 4 capsules of JP consumed daily for 12 weeks increased serum levels of
most carotenoids and α-tocopherol but failed to modulate the expression of p27
and/or Ki-67 levels in HNC patients. We also did not observe any effects of age,
tumor characteristics (ie, site and stage), and continued tobacco and/or alcohol use
on p27, Ki-67, or SPTs in these patients. Longer use of JP also did not appear to be
associated with SPTs. Future studies should evaluate longer supplementation period,
modified formulations of supplements with demonstrated chemopreventive properties in
preclinical models, nutritional status, and the role of oxidative stress and
inflammatory markers on SPT in this population.</p>
            </sec>
          </body>
          <back>
            <ack>
              <p>We dedicate this article to the memory of Dr Venetta Thomas. The authors would like
to acknowledge the invaluable contribution of the Wake Forest Research Base staff
(Gina Enevold, Del Jones, Cissy Yates, and Robin Rosdhal) and the staff at each of
the participating sites (Wake Forest School of Medicine, Southeast Cancer Control
Consortium, Upstate Carolina CCOP, Central Illinois CCOP, East Carolina University,
Harbin Clinic Radiation Oncology, Greater Phoenix CCOP, Alamance Cancer Center, and
Louisiana State University MBCCOP) without whom this study would not have been
feasible. Sample analyses were conducted by J. Mark Morris in the laboratory of Dr
Mark Lively at Wake Forest School of Medicine.</p>
            </ack>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Authors’ Note:</bold> Clinical trial registration number: NCT00064298. <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00064298?term=%22juice+plus%22+AND+%22head+and+neck+cancer%22&amp;rank=1">https://clinicaltrials.gov/ct2/show/NCT00064298?term=%22juice+plus%22+AND+%22head+and+neck+cancer%22&amp;rank=1</ext-link>.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This study was
supported by NSA, Inc and NIH/NCI grants U10 CA 81851 and R21 CA 106205. The
first author was supported by the Comprehensive Cancer Center of Wake Forest
University Cancer Control Traineeship, NCI/NIH Grant# R25CA122061. Funders had
no role in the design and implementation of the study, interpretation of
results, or drafting of the manuscript.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="bibr1-1534735416684947">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seven</surname><given-names>A</given-names></name><name><surname>Civelek</surname><given-names>S</given-names></name><name><surname>İnci</surname><given-names>E</given-names></name><name><surname>İnci</surname><given-names>F</given-names></name><name><surname>Korkut</surname><given-names>N</given-names></name><name><surname>Burçak</surname><given-names>G</given-names></name></person-group><article-title>Evaluation of oxidative stress parameters in
blood of patients with laryngeal carcinoma</article-title>. <source>Clin
Biochem</source>.
<year>1999</year>;<volume>32</volume>:<fpage>369</fpage>-<lpage>373</lpage>.<pub-id pub-id-type="pmid">10480452</pub-id></mixed-citation>
              </ref>
              <ref id="bibr2-1534735416684947">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cloos</surname><given-names>J</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name><name><surname>van der Sterre</surname><given-names>MLT</given-names></name><name><surname>Kuik</surname><given-names>DJ</given-names></name><name><surname>Snow</surname><given-names>GB</given-names></name><name><surname>Braakhuis</surname><given-names>BJM</given-names></name></person-group><article-title>Mutagen sensitivity as a biomarker for second
primary tumors after head and neck squamous cell carcinoma</article-title>.
<source>Cancer Epidemiol Biomarkers Prev</source>.
<year>2000</year>;<volume>9</volume>:<fpage>713</fpage>-<lpage>717</lpage>.<pub-id pub-id-type="pmid">10919742</pub-id></mixed-citation>
              </ref>
              <ref id="bibr3-1534735416684947">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmezer</surname><given-names>P</given-names></name><name><surname>Rupprecht</surname><given-names>T</given-names></name><name><surname>Tisch</surname><given-names>M</given-names></name><name><surname>Maier</surname><given-names>H</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><article-title>Laryngeal mucosa of head and neck cancer
patients shows increased DNA damage as detected by single cell microgel
electrophoresis</article-title>. <source>Toxicology</source>.
<year>2000</year>;<volume>144</volume>:<fpage>149</fpage>-<lpage>154</lpage>.<pub-id pub-id-type="pmid">10781882</pub-id></mixed-citation>
              </ref>
              <ref id="bibr4-1534735416684947">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>LH</given-names></name><name><surname>Ozsahin</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>GN</given-names></name><etal>et al</etal></person-group><article-title>Synchronous and metachronous head and neck
carcinomas</article-title>. <source>Cancer</source>.
<year>1994</year>;<volume>74</volume>:<fpage>1933</fpage>-<lpage>1938</lpage>.<pub-id pub-id-type="pmid">8082099</pub-id></mixed-citation>
              </ref>
              <ref id="bibr5-1534735416684947">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Mogi</surname><given-names>K</given-names></name></person-group><article-title>Immunohistochemical analysis of cell
cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and
precancer with special reference to verrucous carcinomas</article-title>.
<source>J Oral Pathol Med</source>.
<year>1999</year>;<volume>28</volume>:<fpage>226</fpage>-<lpage>232</lpage>.<pub-id pub-id-type="pmid">10226946</pub-id></mixed-citation>
              </ref>
              <ref id="bibr6-1534735416684947">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>De Angelis</surname><given-names>P</given-names></name><name><surname>Clausen</surname><given-names>OPF</given-names></name><name><surname>Boysen</surname><given-names>M</given-names></name></person-group><article-title>Prognostic significance of proliferative and
apoptotic markers in oral tongue squamous cell carcinomas</article-title>.
<source>Oral Oncol</source>.
<year>1999</year>;<volume>35</volume>:<fpage>502</fpage>-<lpage>509</lpage>.<pub-id pub-id-type="pmid">10694951</pub-id></mixed-citation>
              </ref>
              <ref id="bibr7-1534735416684947">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mineta</surname><given-names>H</given-names></name><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>I</given-names></name><etal>et al</etal></person-group><article-title>Low p27 expression correlates with poor
prognosis for patients with oral tongue squamous cell
carcinoma</article-title>. <source>Cancer</source>.
<year>1999</year>;<volume>85</volume>:<fpage>1011</fpage>-<lpage>1017</lpage>.<pub-id pub-id-type="pmid">10091782</pub-id></mixed-citation>
              </ref>
              <ref id="bibr8-1534735416684947">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudo</surname><given-names>Y</given-names></name><name><surname>Takata</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>I</given-names></name><etal>et al</etal></person-group><article-title>Reduced expression of p27Kip1 correlates with an
early stage of cancer invasion in oral squamous cell
carcinoma</article-title>. <source>Cancer Lett</source>.
<year>2000</year>;<volume>151</volume>:<fpage>217</fpage>-<lpage>222</lpage>.<pub-id pub-id-type="pmid">10738117</pub-id></mixed-citation>
              </ref>
              <ref id="bibr9-1534735416684947">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edefonti</surname><given-names>V</given-names></name><name><surname>Hashibe</surname><given-names>M</given-names></name><name><surname>Ambrogi</surname><given-names>F</given-names></name><etal>et al</etal></person-group><article-title>Nutrient-based dietary patterns and the risk of
head and neck cancer: a pooled analysis in the International Head and Neck
Cancer Epidemiology consortium</article-title>. <source>Ann Oncol</source>.
<year>2012</year>;<volume>23</volume>:<fpage>1869</fpage>-<lpage>1880</lpage>.<pub-id pub-id-type="pmid">22123733</pub-id></mixed-citation>
              </ref>
              <ref id="bibr10-1534735416684947">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>S-C</given-names></name><name><surname>Jenab</surname><given-names>M</given-names></name><name><surname>Heck</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Diet and the risk of head and neck cancer: a
pooled analysis in the INHANCE consortium</article-title>. <source>Cancer
Causes Control</source>.
<year>2012</year>;<volume>23</volume>:<fpage>69</fpage>-<lpage>88</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr11-1534735416684947">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>HJ</given-names></name><name><surname>Heimendinger</surname><given-names>J</given-names></name><name><surname>Haegele</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Effect of increased vegetable and fruit
consumption on markers of oxidative cellular damage</article-title>.
<source>Carcinogenesis</source>.
<year>1999</year>;<volume>20</volume>:<fpage>2261</fpage>-<lpage>2266</lpage>.<pub-id pub-id-type="pmid">10590217</pub-id></mixed-citation>
              </ref>
              <ref id="bibr12-1534735416684947">
                <label>12</label>
                <mixed-citation publication-type="gov"><collab>National Cancer Institute</collab>. <article-title>Usual dietary
intakes: food intakes, U.S. population, 2007-10</article-title>. <ext-link ext-link-type="uri" xlink:href="http://epi.grants.cancer.gov/diet/usualintakes/pop/2007-10/">http://epi.grants.cancer.gov/diet/usualintakes/pop/2007-10/</ext-link>.
<comment>Accessed July 17, 2015</comment>.</mixed-citation>
              </ref>
              <ref id="bibr13-1534735416684947">
                <label>13</label>
                <mixed-citation publication-type="web"><collab>American Cancer Society</collab>. <article-title>Cancer facts and
figures 2014</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/">http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/</ext-link>.
<comment>Accessed March 12, 2014</comment>.</mixed-citation>
              </ref>
              <ref id="bibr14-1534735416684947">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClure</surname><given-names>JB</given-names></name><name><surname>Divine</surname><given-names>G</given-names></name><name><surname>Alexander</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>A comparison of smokers’ and nonsmokers’ fruit
and vegetable intake and relevant psychosocial factors</article-title>.
<source>Behav Med</source>.
<year>2009</year>;<volume>35</volume>:<fpage>14</fpage>-<lpage>22</lpage>.<pub-id pub-id-type="pmid">19297300</pub-id></mixed-citation>
              </ref>
              <ref id="bibr15-1534735416684947">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osler</surname><given-names>M</given-names></name><name><surname>Tjønneland</surname><given-names>A</given-names></name><name><surname>Suntum</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Does the association between smoking status and
selected healthy foods depend on gender? A population-based study of 54 417
middle-aged Danes</article-title>. <source>Eur J Clin Nutr</source>.
<year>2002</year>;<volume>56</volume>:<fpage>57</fpage>-<lpage>63</lpage>.<pub-id pub-id-type="pmid">11840181</pub-id></mixed-citation>
              </ref>
              <ref id="bibr16-1534735416684947">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morabia</surname><given-names>A</given-names></name><name><surname>Wynder</surname><given-names>EL</given-names></name></person-group><article-title>Dietary habits of smokers, people who never
smoked, and exsmokers</article-title>. <source>Am J Clin Nutr</source>.
<year>1990</year>;<volume>52</volume>:<fpage>933</fpage>-<lpage>937</lpage>.<pub-id pub-id-type="pmid">2239771</pub-id></mixed-citation>
              </ref>
              <ref id="bibr17-1534735416684947">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>B</given-names></name><name><surname>Forte</surname><given-names>TM</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name><name><surname>Cross</surname><given-names>CE</given-names></name></person-group><article-title>Gas phase oxidants of cigarette smoke induce
lipid peroxidation and changes in lipoprotein properties in human blood
plasma: protective effects of ascorbic acid</article-title>. <source>Biochem
J</source>.
<year>1991</year>;<volume>277</volume>:<fpage>133</fpage>-<lpage>138</lpage>.<pub-id pub-id-type="pmid">1854329</pub-id></mixed-citation>
              </ref>
              <ref id="bibr18-1534735416684947">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eiserich</surname><given-names>JP</given-names></name><name><surname>van der Vliet</surname><given-names>A</given-names></name><name><surname>Handelman</surname><given-names>GJ</given-names></name><name><surname>Halliwell</surname><given-names>B</given-names></name><name><surname>Cross</surname><given-names>CE</given-names></name></person-group><article-title>Dietary antioxidants and cigarette smoke-induced
biomolecular damage: a complex interaction</article-title>. <source>Am J
Clin Nutr</source>. <year>1995</year>;<volume>62</volume>(<issue>6,
suppl</issue>):<fpage>1490S</fpage>-<lpage>1500S</lpage>.<pub-id pub-id-type="pmid">7495250</pub-id></mixed-citation>
              </ref>
              <ref id="bibr19-1534735416684947">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marangon</surname><given-names>K</given-names></name><name><surname>Herbeth</surname><given-names>B</given-names></name><name><surname>Lecomte</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Diet, antioxidant status, and smoking habits in
French men</article-title>. <source>Am J Clin Nutr</source>.
<year>1998</year>;<volume>67</volume>:<fpage>231</fpage>-<lpage>239</lpage>.<pub-id pub-id-type="pmid">9459370</pub-id></mixed-citation>
              </ref>
              <ref id="bibr20-1534735416684947">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lykkesfeldt</surname><given-names>J</given-names></name><name><surname>Christen</surname><given-names>S</given-names></name><name><surname>Wallock</surname><given-names>LM</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Jacob</surname><given-names>RA</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name></person-group><article-title>Ascorbate is depleted by smoking and repleted by
moderate supplementation: a study in male smokers and nonsmokers with
matched dietary antioxidant intakes</article-title>. <source>Am J Clin
Nutr</source>.
<year>2000</year>;<volume>71</volume>:<fpage>530</fpage>-<lpage>536</lpage>.<pub-id pub-id-type="pmid">10648268</pub-id></mixed-citation>
              </ref>
              <ref id="bibr21-1534735416684947">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><etal>et al</etal></person-group><article-title>Long-term impact of smoking on lung epithelial
proliferation in current and former smokers</article-title>. <source>J Natl
Cancer Inst</source>.
<year>2001</year>;<volume>93</volume>:<fpage>1081</fpage>-<lpage>1088</lpage>.<pub-id pub-id-type="pmid">11459869</pub-id></mixed-citation>
              </ref>
              <ref id="bibr22-1534735416684947">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Albert</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Vitamins C and E and beta carotene
supplementation and cancer risk: a randomized controlled
trial</article-title>. <source>J Natl Cancer Inst</source>.
<year>2009</year>;<volume>101</volume>:<fpage>14</fpage>-<lpage>23</lpage>.<pub-id pub-id-type="pmid">19116389</pub-id></mixed-citation>
              </ref>
              <ref id="bibr23-1534735416684947">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bairati</surname><given-names>I</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Gélinas</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>A randomized trial of antioxidant vitamins to
prevent second primary cancers in head and neck cancer
patients</article-title>. <source>J Natl Cancer Inst</source>.
<year>2005</year>;<volume>97</volume>:<fpage>481</fpage>-<lpage>488</lpage>.<pub-id pub-id-type="pmid">15812073</pub-id></mixed-citation>
              </ref>
              <ref id="bibr24-1534735416684947">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>ME</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Hartman</surname><given-names>AM</given-names></name><etal>et al</etal></person-group><article-title>Effects of alpha-tocopherol and beta-carotene
supplementation on upper aerodigestive tract cancers in a large, randomized
controlled trial</article-title>. <source>Cancer</source>.
<year>2007</year>;<volume>109</volume>:<fpage>891</fpage>-<lpage>898</lpage>.<pub-id pub-id-type="pmid">17265529</pub-id></mixed-citation>
              </ref>
              <ref id="bibr25-1534735416684947">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Heinonen</surname><given-names>OP</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><etal>et al</etal></person-group><article-title>Alpha-tocopherol and beta-carotene supplements
and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer
prevention study: effects of base-line characteristics and study
compliance</article-title>. <source>J Natl Cancer Inst</source>.
<year>1996</year>;<volume>88</volume>:<fpage>1560</fpage>-<lpage>1570</lpage>.<pub-id pub-id-type="pmid">8901854</pub-id></mixed-citation>
              </ref>
              <ref id="bibr26-1534735416684947">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippman</surname><given-names>SM</given-names></name><name><surname>Klein</surname><given-names>EA</given-names></name><name><surname>Goodman</surname><given-names>PJ</given-names></name><etal>et al</etal></person-group><article-title>Effect of selenium and vitamin E on risk of
prostate cancer and other cancers: the Selenium and Vitamin E Cancer
Prevention Trial (SELECT)</article-title>. <source>JAMA</source>.
<year>2009</year>;<volume>301</volume>:<fpage>39</fpage>-<lpage>51</lpage>.<pub-id pub-id-type="pmid">19066370</pub-id></mixed-citation>
              </ref>
              <ref id="bibr27-1534735416684947">
                <label>27</label>
                <mixed-citation publication-type="journal"><collab>The Alpha-Tocopherol Beta Carotene Cancer Prevention Study
Group</collab>. <article-title>The effect of vitamin E and beta carotene on
the incidence of lung cancer and other cancers in male
smokers</article-title>. <source>N Engl J Med</source>.
<year>1994</year>;<volume>330</volume>:<fpage>1029</fpage>-<lpage>1035</lpage>.<pub-id pub-id-type="pmid">8127329</pub-id></mixed-citation>
              </ref>
              <ref id="bibr28-1534735416684947">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nantz</surname><given-names>MP</given-names></name><name><surname>Rowe</surname><given-names>CA</given-names></name><name><surname>Nieves</surname><given-names>C</given-names></name><name><surname>Percival</surname><given-names>SS</given-names></name></person-group><article-title>Immunity and antioxidant capacity in humans is
enhanced by consumption of a dried, encapsulated fruit and vegetable juice
concentrate</article-title>. <source>J Nutr</source>.
<year>2006</year>;<volume>136</volume>:<fpage>2606</fpage>-<lpage>2610</lpage>.<pub-id pub-id-type="pmid">16988134</pub-id></mixed-citation>
              </ref>
              <ref id="bibr29-1534735416684947">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Singh</surname><given-names>UP</given-names></name><etal>et al</etal></person-group><article-title>Systemic inflammatory load in humans is
suppressed by consumption of two formulations of dried, encapsulated juice
concentrate</article-title>. <source>Mol Nutr Food Res</source>.
<year>2010</year>;<volume>54</volume>:<fpage>1506</fpage>-<lpage>1514</lpage>.<pub-id pub-id-type="pmid">20425759</pub-id></mixed-citation>
              </ref>
              <ref id="bibr30-1534735416684947">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Singh</surname><given-names>UP</given-names></name><etal>et al</etal></person-group><article-title>Suppression of DNA damage in human peripheral
blood lymphocytes by a juice concentrate: a randomized, double-blind,
placebo-controlled trial</article-title>. <source>Mol Nutr Food
Res</source>.
<year>2012</year>;<volume>56</volume>:<fpage>666</fpage>-<lpage>670</lpage>.<pub-id pub-id-type="pmid">22383296</pub-id></mixed-citation>
              </ref>
              <ref id="bibr31-1534735416684947">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeds</surname><given-names>AR</given-names></name><name><surname>Ferris</surname><given-names>EAE</given-names></name><name><surname>Staley</surname><given-names>J</given-names></name><name><surname>Ayesh</surname><given-names>R</given-names></name><name><surname>Ross</surname><given-names>F</given-names></name></person-group><article-title>Availability of micronutrients from dried,
encapsulated fruit and vegetable preparations: a study in healthy
volunteers</article-title>. <source>J Hum Nutr Diet</source>.
<year>2000</year>;<volume>13</volume>:<fpage>21</fpage>-<lpage>27</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr32-1534735416684947">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samman</surname><given-names>S</given-names></name><name><surname>Sivarajah</surname><given-names>G</given-names></name><name><surname>Man</surname><given-names>JC</given-names></name><name><surname>Ahmad</surname><given-names>ZI</given-names></name><name><surname>Petocz</surname><given-names>P</given-names></name><name><surname>Caterson</surname><given-names>ID</given-names></name></person-group><article-title>A mixed fruit and vegetable concentrate
increases plasma antioxidant vitamins and folate and lowers plasma
homocysteine in men</article-title>. <source>J Nutr</source>.
<year>2003</year>;<volume>133</volume>:<fpage>2188</fpage>-<lpage>2193</lpage>.<pub-id pub-id-type="pmid">12840177</pub-id></mixed-citation>
              </ref>
              <ref id="bibr33-1534735416684947">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MJ</given-names></name><name><surname>Inserra</surname><given-names>PF</given-names></name><name><surname>Watson</surname><given-names>RR</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name><name><surname>O’Neill</surname><given-names>KL</given-names></name></person-group><article-title>Supplementation with fruit and vegetable
extracts may decrease DNA damage in the peripheral lymphocytes of an elderly
population</article-title>. <source>Nutr Res</source>.
<year>1999</year>;<volume>19</volume>:<fpage>1507</fpage>-<lpage>1518</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr34-1534735416684947">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paxton</surname><given-names>RJ</given-names></name><name><surname>Garcia-Prieto</surname><given-names>C</given-names></name><name><surname>Berglund</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>A randomized parallel-group dietary study for
stages II-IV ovarian cancer survivors</article-title>. <source>Gynecol
Oncol</source>.
<year>2012</year>;<volume>124</volume>:<fpage>410</fpage>-<lpage>416</lpage>.<pub-id pub-id-type="pmid">22119991</pub-id></mixed-citation>
              </ref>
              <ref id="bibr35-1534735416684947">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname><given-names>D</given-names></name><name><surname>Keller</surname><given-names>HE</given-names></name><name><surname>Oberlin</surname><given-names>B</given-names></name><name><surname>Bonfanti</surname><given-names>R</given-names></name><name><surname>Schüep</surname><given-names>W</given-names></name></person-group><article-title>Simultaneous determination of retinol,
tocopherols, carotenes and lycopene in plasma by means of high-performance
liquid chromatography on reversed phase</article-title>. <source>Int J Vitam
Nutr Res</source>.
<year>1991</year>;<volume>61</volume>:<fpage>232</fpage>-<lpage>238</lpage>.<pub-id pub-id-type="pmid">1794952</pub-id></mixed-citation>
              </ref>
              <ref id="bibr36-1534735416684947">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aebischer</surname><given-names>CP</given-names></name><name><surname>Schierle</surname><given-names>J</given-names></name><name><surname>Schüep</surname><given-names>W</given-names></name></person-group><article-title>Simultaneous determination of retinol,
tocopherols, carotene, lycopene, and xanthophylls in plasma by means of
reversed-phase high-performance liquid chromatography</article-title>.
<source>Methods Enzymol</source>.
<year>1999</year>;<volume>299</volume>:<fpage>348</fpage>-<lpage>362</lpage>.<pub-id pub-id-type="pmid">9916214</pub-id></mixed-citation>
              </ref>
              <ref id="bibr37-1534735416684947">
                <label>37</label>
                <mixed-citation publication-type="gov"><collab>National Cancer Institute, Cancer Therapy Evaluation Program</collab>.
<article-title>Common Terminology Criteria for Adverse Events v
3.0</article-title>. <year>2006</year><ext-link ext-link-type="uri" xlink:href="http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf">http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf</ext-link>.
<comment>Accessed December 23, 2007</comment>.</mixed-citation>
              </ref>
              <ref id="bibr38-1534735416684947">
                <label>38</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fitzmaurice</surname><given-names>GM</given-names></name><name><surname>Laird</surname><given-names>NM</given-names></name><name><surname>Ware</surname><given-names>JH</given-names></name></person-group><source>Applied Longitudinal Analysis</source>.
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>John
Wiley</publisher-name>; <year>2011</year>.</mixed-citation>
              </ref>
              <ref id="bibr39-1534735416684947">
                <label>39</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Therneau</surname><given-names>TM</given-names></name><name><surname>Grambsch</surname><given-names>PM</given-names></name></person-group><source>Modeling Survival Data: Extending the Cox
Model</source>. <publisher-loc>New York, NY</publisher-loc>:
<publisher-name>Springer-Verlag</publisher-name>;
<year>2000</year>.</mixed-citation>
              </ref>
              <ref id="bibr40-1534735416684947">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hittelman</surname><given-names>WN</given-names></name><name><surname>Liu</surname><given-names>DD</given-names></name><name><surname>Kurie</surname><given-names>JM</given-names></name><etal>et al</etal></person-group><article-title>Proliferative changes in the bronchial
epithelium of former smokers treated with retinoids</article-title>.
<source>J Natl Cancer Inst</source>.
<year>2007</year>;<volume>99</volume>:<fpage>1603</fpage>-<lpage>1612</lpage>.<pub-id pub-id-type="pmid">17971525</pub-id></mixed-citation>
              </ref>
              <ref id="bibr41-1534735416684947">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>J</given-names></name><name><surname>Picinich</surname><given-names>SC</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><etal>et al</etal></person-group><article-title>Cancer-preventive activities of tocopherols and
tocotrienols</article-title>. <source>Carcinogenesis</source>.
<year>2010</year>;<volume>31</volume>:<fpage>533</fpage>-<lpage>542</lpage>.<pub-id pub-id-type="pmid">19748925</pub-id></mixed-citation>
              </ref>
              <ref id="bibr42-1534735416684947">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>S-K</given-names></name><etal>et al</etal></person-group><article-title>Anticancer actions of natural and synthetic
vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of
gamma-tocopherol</article-title>. <source>Mol Nutr Food Res</source>.
<year>2009</year>;<volume>53</volume>:<fpage>1573</fpage>-<lpage>1581</lpage>.<pub-id pub-id-type="pmid">19842103</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
